Spots Global Cancer Trial Database for memantine hydrochloride

Every month we try and update this database with for memantine hydrochloride cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors	NCT04217694	Malignant Centr... Primary Central...	Cogstate Assess... Memantine Memantine Hydro...	4 Years - 18 Years	Mayo Clinic
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability	NCT04804644	Metastatic Lung... Metastatic Mali... Recurrent Lung ... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ...	Memantine Hydro... Neurocognitive ... Stereotactic Ra... Whole-Brain Rad...	18 Years -	NRG Oncology
Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy	NCT01430351	Glioblastoma Gliosarcoma Supratentorial ...	Mefloquine Memantine Hydro... Metformin Hydro... Temozolomide	18 Years -	M.D. Anderson Cancer Center
Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking	NCT01535040	Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Tobacco Use Dis...	memantine hydro... placebo	18 Years -	Wake Forest University Health Sciences
Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastases	NCT04801342	Metastatic Mali...	Conformal Whole... Conformal Whole... Memantine Hydro...	20 Years -	National Taiwan University Hospital
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability	NCT04804644	Metastatic Lung... Metastatic Mali... Recurrent Lung ... Stage IV Lung C... Stage IVA Lung ... Stage IVB Lung ...	Memantine Hydro... Neurocognitive ... Stereotactic Ra... Whole-Brain Rad...	18 Years -	NRG Oncology
Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastases	NCT04801342	Metastatic Mali...	Conformal Whole... Conformal Whole... Memantine Hydro...	20 Years -	National Taiwan University Hospital
Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking	NCT01535040	Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Tobacco Use Dis...	memantine hydro... placebo	18 Years -	Wake Forest University Health Sciences
A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for Primary Central Nervous System Tumors	NCT04939597	Central Nervous...	Biospecimen Col... Cognitive Asses... Magnetic Resona... Memantine Hydro... Placebo Adminis... Questionnaire A...	4 Years - 17 Years	Children's Oncology Group
Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking	NCT01535040	Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Tobacco Use Dis...	memantine hydro... placebo	18 Years -	Wake Forest University Health Sciences
Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors	NCT04217694	Malignant Centr... Primary Central...	Cogstate Assess... Memantine Memantine Hydro...	4 Years - 18 Years	Mayo Clinic

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: